Los Angeles, CA (January 6, 2015) – StoneCalibre is pleased to announce that its portfolio company, Anatrace, has completed the acquisition of Microlytic, a provider of innovative life science tools and reagents to the structural biology market. Microlytic’s solutions represent the most productive approaches to soluble protein crystallization, which allow researchers to accelerate workflow, increase output quality and help solve the major problem in structural biology: crystal formation.
“Microlytic will add to Anatrace’s market leading portfolio of high-purity detergents and synthetic lipids, including the co-developed Analytic product line,” said Brian Wall, Founder and Chief Executive Officer of StoneCalibre. “We will continue to look for strategic acquisitions, such as Microlytic, to supplement Anatrace’s organic growth and as a means to broaden our product offering and expand our customer base.”
Dr. Ben Travis, CEO of Anatrace, expressed his enthusiasm for the transaction. “We have been impressed by the Microlytic team and their track record of innovation in the structural biology market and look forward to working together towards achieving the high standards that have come to define Anatrace.” Dr. Travis stated, “With the acquisition of Microlytic we are able to deliver a comprehensive and innovative set of solutions that will further advance the important field of protein biology research.”
The terms of the transaction were not disclosed.
Headquartered in Century City, CA, StoneCalibre is a privately funded investment firm specializing in the acquisition of lower middle market companies. Founded by Brian Wall in 2012, StoneCalibre is focused on making investments in both special situations and quality long-term capital investment opportunities. For more information please visit our website at www.stonecalibre.com.
Anatrace is a developer, manufacturer, and distributor of approximately 250 high-purity detergents and synthetic lipids for use in membrane protein research studies headquartered in Maumee, OH. With nearly 30 years of experience, Anatrace’s products allow researchers to extract, purify, manipulate and crystallize cell membrane proteins, which serve multiple key functions in a cell including molecule transport, signal reception, cell adhesion, and account for approximately 30% of proteins encoded by the human genome. For more information, visit www.anatrace.com.